Richard Cui

Dr. Richard Cui


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Epilepsia
Verified
Journal Article
Closed access
NGNicholas M. Gregg
Nicholas M. Gregg
TATal Pal Attia
Tal Pal Attia
MNMona Nasseri
Mona Nasseri
Boney JosephBoney Joseph
Boney Joseph
PKPhilippa Karoly
Philippa Karoly
BBBenjamin H. Brinkmann
Benjamin H. Brinkmann

1 April 2024 in Journal of Neural Engineering
Verified
Journal Article
Closed access
RCRichard Cui
Richard Cui
FMFilip Mivalt
Filip Mivalt
VSVladimir Sladky
Vladimir Sladky
JKJiwon Kim
Jiwon Kim
TRThomas J Richner
Thomas J Richner
GWGregory A Worrell
Gregory A Worrell
Objective. This study aims to characterize the time course of impedance, a crucial electrophysiological property of brain tissue, in the human thalamus (THL), amygdala-hippocampus, and posterior hippocampus over an extended period. Approach. Impedance was periodically sampled every 5–15 min over several months in five subjects with drug-resistant epilepsy using an investigational neuromodulation device. Initially, we employed descriptive piecewise and continuous mathematical models to characterize the impedance response for approximately three weeks post-electrode implantation. We then explored the temporal dynamics of impedance during periods when electrical stimulation was temporarily halted, observing a monotonic increase (rebound) in impedance before it stabilized at a higher value. Lastly, we assessed the stability of amplitude and phase over the 24 h impedance cycle throughout the multi-month recording. Main results. Immediately post-implantation, the impedance decreased, reaching a minimum value in all brain regions within approximately two days, and then increased monotonically over about 14 d to a stable value. The models accounted for the variance in short-term impedance changes. Notably, the minimum impedance of the THL in the most epileptogenic hemisphere was significantly lower than in other regions. During the gaps in electrical stimulation, the impedance rebound decreased over time and stabilized around 200 days post-implant, likely indicative of the foreign body response and fibrous tissue encapsulation around the electrodes. The amplitude and phase of the 24 h impedance oscillation remained stable throughout the multi-month recording, with circadian variation in impedance dominating the long-term measures. Significance. Our findings illustrate the complex temporal dynamics of impedance in implanted electrodes and the impact of electrical stimulation. We discuss these dynamics in the context of the known biological foreign body response of the brain to implanted electrodes. The data suggest that the temporal dynamics of impedance are dependent on the anatomical location and tissue epileptogenicity. These insights may offer additional guidance for the delivery of therapeutic stimulation at various time points post-implantation for neuromodulation therapy.

19 June 2023 in Epilepsia
Verified
Journal Article
Closed access
RCRichard Cui
Richard Cui
IBIrena Balzekas
Irena Balzekas
ENEwan Nurse
Ewan Nurse
PVPedro Viana
Pedro Viana
NGNicholas Gregg
Nicholas Gregg
BBBenjamin H. Brinkmann
Benjamin H. Brinkmann

6 September 2025 in Sensors
Verified
Journal Article
Open access
PDF file
Louis FaustLouis Faust
Louis Faust
RCRichard Cui
Richard Cui
CKCamille Knepper
Camille Knepper
MNMona Nasseri
Mona Nasseri
GWGregory Worrell
Gregory Worrell
BBBenjamin H. Brinkmann
Benjamin H. Brinkmann
Objective: To evaluate the feasibility and effectiveness of wrist-worn wearable devices combined with machine learning (ML) approaches for detecting a diverse array of seizure types beyond generalized tonic–clonic (GTC), including focal, generalized, and subclinical seizures. Materials and Methods: Twenty-eight patients undergoing inpatient video-EEG monitoring at Mayo Clinic were concurrently monitored using Empatica E4 wrist-worn devices. These devices captured accelerometry, blood volume pulse, electrodermal activity, skin temperature, and heart rate. Seizures were annotated by neurologists. The data were preprocessed to experiment with various segment lengths (10 s and 60 s) and multiple feature sets. Three ML strategies, XGBoost, deep learning models (LSTM, CNN, Transformer), and ROCKET, were evaluated using leave-one-patient-out cross-validation. Performance was assessed using area under the receiver operating characteristic curve (AUROC), seizure-wise recall (SW-Recall), and false alarms per hour (FA/h). Results: Detection performance varied by seizure type and model. GTC seizures were detected most reliably (AUROC = 0.86, SW-Recall = 0.81, FA/h = 3.03). Hyperkinetic and tonic seizures showed high SW-Recall but also high FA/h. Subclinical and aware-dyscognitive seizures exhibited the lowest SW-Recall and highest FA/h. MultiROCKET and XGBoost performed best overall, though no single model was optimal for all seizure types. Longer segments (60 s) generally reduced FA/h. Feature set effectiveness varied, with multi-biosignal sets improving performance across seizure types. Conclusions: Wrist-worn wearables combined with ML can extend seizure detection beyond GTC seizures, though performance remains limited for non-motor types. Optimizing model selection, feature sets, and segment lengths, and minimizing false alarms, are key to clinical utility and real-world adoption.

11 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
Vaclav KremenVaclav Kremen
Vaclav Kremen
VSVladimir Sladky
Vladimir Sladky
FMFilip Mivalt
Filip Mivalt
NGNicholas M. Gregg
Nicholas M. Gregg
IBIrena Balzekas
Irena Balzekas
GWGregory A. Worrell
Gregory A. Worrell
Temporal lobe epilepsy is a common neurological disease characterized by recurrent seizures. These seizures often originate from limbic networks and people also experience chronic comorbidities related to memory, mood, and sleep (MMS). Deep brain stimulation targeting the anterior nucleus of the thalamus (ANT-DBS) is a proven therapy, but the optimal stimulation parameters remain unclear. We developed a neurotechnology platform for tracking seizures and MMS to enable data streaming between an investigational brain sensing-stimulation implant, mobile devices, and a cloud environment. Artificial Intelligence algorithms provided accurate catalogs of seizures, interictal epileptiform spikes, and wake-sleep brain states. Remotely administered memory and mood assessments were used to densely sample cognitive and behavioral response during ANT-DBS. We evaluated the efficacy of low-frequency versus high-frequency ANT-DBS. They both reduced seizures, but low-frequency ANT-DBS showed greater reductions and better sleep and memory. These results highlight the potential of synchronized brain sensing and behavioral tracking for optimizing neuromodulation therapy.